Advertisement

Vitamin K antagonist-associated microscopic hematuria

      Abstract

      Background

      Vitamin K antagonists (VKA) are the most widely used anticoagulants for the prevention of thrombotic events. Several renal adverse effects have been associated with the use of VKA. The main aim of our study was to explore the association between international normalized ratio (INR) levels and microscopic hematuria in patients with VKA.

      Methods

      We performed a cross-sectional study of patients treated with VKA that attended the outpatient clinic for routine INR control. A simple urinalysis was performed on the day of the INR control and the precise number of red cells in the urine sediment was quantified. Demographic data, kidney function tests, comorbidities, anticoagulant dose and concomitant treatment were registered.

      Results

      A total of 337 patients were included with median INR levels of 2.6 (IQR 2.1–3.3). 11.9% of the patients presented microscopic hematuria (≥14 RBCs/µl). There was a significant correlation between INR levels and the number of red blood cells in the urine sediment (r = 0.201, p = 0.024). In the univariate analysis, microscopic hematuria was associated with having an INR >3.5 (19% vs. 10.2%, p = 0.046), bacteriuria (15.2% vs. 3.6%, p = 0.015), leukocyturia (14.8% vs. 6.6%, p =  0.026), hypertension (16.2% vs. 9.5%, p = 0.053), and the use of renin-angiotensin system (RAS) blockers (6.9% vs. 17.2%, p = 0.004). Multivariate logistic regression showed an association between microscopic hematuria and RAS blockade (OR 0.38, CI 95% 0.163-0.886, p = 0.025), independent from INR levels, hypertension, leukocyturia or bacteriuria.

      Conclusions

      INR overdose was significantly associated with the presence of microscopic hematuria. RAS blockade is an independent protective factor for the presence of microscopic hematuria in anticoagulated patients.

      Key Indexing Terms

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to The American Journal of the Medical Sciences
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Bhatt N.R.
        • Davis N.F.
        • Nolan W.J.
        • et al.
        Incidence of visible hematuria among antithrombotic agents: a systematic review of over 175,000 patients.
        Urology. 2018; 114: 27-32https://doi.org/10.1016/j.urology.2017.11.023
        • Culclasure T.F.
        • Bray V.J.
        • Hasbargen J.A.
        The significance of hematuria in the anticoagulated patient.
        Arch Intern Med. 1994; 154: 649-652
        • Grossfeld G.D.
        • Carroll P.R.
        Evaluation of asymptomatic microscopic hematuria.
        Urol Clin North Am. 1998; 25: 661-676https://doi.org/10.1016/s0094-0143(05)70055-0
        • Mladenov B.S.
        • Mariyanovski V.
        • Hadzhiyska V.
        Macroscopic hematuria in patients on anticoagulation therapy.
        Cent Eur J Urol. 2015; 68: 330-333https://doi.org/10.5173/ceju.2015.658
        • Vehaskari V.M.
        • Rapola J.
        • Koskimies O.
        • Savilahti E.
        • Vilska J.
        • Hallman N.
        Microscopic hematuria in school children: epidemiology and clinicopathologic evaluation.
        J Pediatr. 1979; 95: 676-684https://doi.org/10.1016/s0022-3476(79)80710-6
        • Hall C.L.
        • Bradley R.
        • Kerr A.
        • Attoti R.
        • Peat D.
        Clinical value of renal biopsy in patients with asymptomatic microscopic hematuria with and without low-grade proteinuria.
        Clin Nephrol. 2004; 62: 267-272https://doi.org/10.5414/cnp62267
        • Lee Y.M.
        • Baek S.Y.
        • Kim J.H.
        • Kim D.S.
        • Lee J.S.
        • Kim P-K.
        Analysis of renal biopsies performed in children with abnormal findings in urinary mass screening.
        Acta Paediatr. 2006; 95: 849-853https://doi.org/10.1080/08035250600652005
        • Brodsky S.
        • Eikelboom J.
        • Hebert L.A.
        Anticoagulant-related nephropathy.
        J Am Soc Nephrol. 2018; 29: 2787-2793https://doi.org/10.1681/ASN.2018070741
        • Brodsky S.V.
        • Satoskar A.
        • Chen J.
        • et al.
        Acute kidney injury during warfarin therapy associated with obstructive tubular red blood cell casts: a report of 9 cases.
        Am J Kidney Dis. 2009; 54: 1121-1126https://doi.org/10.1053/j.ajkd.2009.04.024
        • Ware K.
        • Qamri Z.
        • Ozcan A.
        • et al.
        N-acetylcysteine ameliorates acute kidney injury but not glomerular hemorrhage in an animal model of warfarin-related nephropathy.
        Am J Physiol Renal Physiol. 2013; 304: F1421-F1427https://doi.org/10.1152/ajprenal.00689.2012
        • Bansal N.
        • Xie D.
        • Tao K.
        • et al.
        Atrial fibrillation and risk of ESRD in adults with CKD.
        Clin J Am Soc Nephrol. 2016; 11: 1189-1196https://doi.org/10.2215/CJN.10921015